Postmenopausal women on semaglutide + HT lost significantly more weight than those on semaglutide aloneat every checkpoint: 3, 6, 9, and 12 months
Phys Rev Lett 64:20942097
The main GLP-1 agonist names in India include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Victoza, Saxenda, Lirafit), dulaglutide (Trulicity), and exenatide (Byetta)
When weighed against the financial and health costs of weight regain, including renewed medication courses, worsening metabolic disease, and associated healthcare utilization, the maintenance approach frequently wins on pure economics
This contributes to a more stable secondary structure under laboratory conditions
F.AlhozaliA